Stock data
Rallybio Corporation (RLYB)
Rallybio Corporation (RLYB) reported revenue of US$0.86M and net income of -US$8.98M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.86M | — | -US$33.06M | -US$8.98M | — |
| 2024 | US$0.64M | — | -US$60.50M | -US$57.77M | — |
| 2023 | — | — | -US$78.93M | -US$74.56M | — |
| 2022 | — | — | -US$67.88M | -US$66.65M | — |
| 2021 | — | — | -US$45.65M | -US$47.01M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.00M | US$43.66M | — |
| 2026-03-31 | US$0.21M | -US$8.28M | — |
| 2025-12-31 | US$0.22M | -US$5.85M | — |
| 2025-09-30 | US$0.21M | US$16.02M | — |
| 2025-06-30 | US$0.21M | -US$9.70M | — |
| 2025-03-31 | US$0.21M | -US$9.44M | — |
| 2024-12-31 | US$0.04M | -US$11.04M | — |
| 2024-09-30 | US$0.30M | -US$11.47M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.